Clinical implementation of targeted and immunotherapies for advanced RCC

Episode 1 December 14, 2022 00:19:51
Clinical implementation of targeted and immunotherapies for advanced RCC
COR2ED Medical Education
Clinical implementation of targeted and immunotherapies for advanced RCC

Dec 14 2022 | 00:19:51

/

Show Notes

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of Brest and Quimper in France, discuss the clinical implementation of targeted and immunotherapies for advanced renal cell carcinoma (RCC).

In this podcast, the two experts discuss data from key trials CHECKMATE 214 (ipilimumab and nivolumab), KEYNOTE 426 (axitinib and pembrolizumab), CHECKMATE 9ER (cabozantinib and nivolumab), CLEAR (Lenvatinib and pembrolizumab) and COSMIC 313 (cabozantinib plus nivolumab and ipilimumab) and the implications for clinical practice.

They also discuss management of toxicities associated with combination treatments, including dosing strategies to ensure the patient remains on optimal treatment and improved education for patients and clinicians so that they recognise side effects and how to manage them.

Other Episodes

Episode 2

February 02, 2023 00:24:10
Episode Cover

Update from ASCO GI 2023 Ep 2: lower GI cancer highlights

COR2ED Medical Education: This episode, covers the highlights on colorectal cancer from ASCO GI 2023.  Prof. Andrea Sartore-Bianchi (Niguada Cancer Center, Milan, Italy) and...

Listen

Episode

January 28, 2022 00:31:03
Episode Cover

Genetic testing and PARP inhibitors in prostate cancer

COR2ED Medical Education: Joanne Chien, Nurse Practitioner specialising in urologic cancers at Stanford Health Care in Palo Alto, California, and Dr Alexander Wyatt, Assistant...

Listen

Episode 3

October 21, 2021 00:17:57
Episode Cover

Current and Future Therapeutic Approaches in Colorectal and Gastric Cancer: Future Developments - Ep 3

In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...

Listen